MindMaze Theraputics
+ Menu
  • Solutions
    • MindMaze platform
      • Our approach
      • Clinical evidence
    • Therapy & monitoring
      • Companion
      • MindMotion GO
      • MindPod
      • Izar
      • Physilog
      • ToapRun
    • Drug development
      • Relief Therapeutics pipeline and portfolio
  • Research & Innovation
    • MindMaze Labs
      • Neurotherapeutics frontiers
      • Research collaborations
      • Human performance
      • Deep technology
  • Investor relations
    • Share price
    • Board & executive team
    • Key stock information
    • Financial reports
    • Articles of association
    • US ADR Program
    • Financial calendar
    • News and Events
    • Shareholder’s general meeting
    • Equity research coverage
    • Investor presentations
    • Investor newsletter
  • About
    • MindMaze Therapeutics
    • Media
    • Careers
    • Testimonials
    • Contact
MindMaze Theralputics
+ Menu
  • Solutions
    • MindMaze platform
      • Our approach
      • Clinical evidence
    • Therapy & monitoring
      • Companion
      • MindMotion GO
      • MindPod
      • Izar
      • Physilog
      • ToapRun
    • Drug development
      • Relief Therapeutics pipeline and portfolio
  • Research & Innovation
    • MindMaze Labs
      • Neurotherapeutics frontiers
      • Research collaborations
      • Human performance
      • Deep technology
  • Investor relations
    • Share price
    • Board & executive team
    • Key stock information
    • Financial reports
    • Articles of association
    • US ADR Program
    • Financial calendar
    • News and Events
    • Shareholder’s general meeting
    • Equity research coverage
    • Investor presentations
    • Investor newsletter
  • About
    • MindMaze Therapeutics
    • Media
    • Careers
    • Testimonials
    • Contact
Investor relations

Shareholder's general meeting

2025

AGM – 12 June | EGM – 14 November

AGM invitation 2025 EN | AGM voting results 2025 | EGM invitation 2025 EN | EGM voting results 2025

2024

AGM – 27 June | EGM – 26 April

AGM invitation 2024 EN | AGM voting result 2024 | EGM invitation 2024 EN | EGM voting results 2024

2023

AGM – 20 June | EGM – 28 April

AGM invitation 2023 EN | AGM voting result 2023 | EGM 2023 invitation EN | Q&A reverse split 2023 EN | EGM voting results 2023

2022

AGM – 31 May | EGM – 28 January

AGM invitation 2022 EN | EGM invitation 2022 EN

2021

AGM – 18 June

AGM invitation 2021 EN

Chemin de Roseneck 5
1006 Lausanne, Switzerland

+41 21 552 08 01
info@mindmaze.com
  • MindMaze platform
  • Therapy & monitoring
  • Drug development
  • Research & innovation
  • Investor relations
  • About
  • Contact
copyright © 2025 | terms and conditions | EU privacy policy | U.S. privacy policy | PERSONAL DATA REQUESTS
We value your privacy
We use cookies to enhance your browsing experience and analyze our traffic. By clicking "I accept", you consent to our use of cookies.